@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-XGBKP9G8-T skos:prefLabel "Anesthetics, Intravenous"@en, "Anesthésiques intraveineux"@fr ; a mesh:Descriptor, skos:Concept . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-RMSM6LXT-R skos:prefLabel "Adjuvants, Anesthesia"@en, "Adjuvants des anesthésiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-CQ2KMNMH-W skos:prefLabel "Piperidines"@en, "Pipéridines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZHWNGWFR-7 . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-SL9SPLFM-9 skos:prefLabel "Sufentanil"@fr, "Sufentanil"@en ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-ZHWNGWFR-7 . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-F32T283B-G skos:prefLabel "Alfentanil"@fr, "Alfentanil"@en ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-ZHWNGWFR-7 . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZHWNGWFR-7 mesh:allowableQualifier jvr:-NHL3D2X0-S, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-H7K65Q8S-Z, jvr:-G30ZJ446-J, jvr:-SBNWSM1T-R, jvr:-BT300B3G-Q, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-CB30NGKB-3, jvr:-WK5F724J-1, jvr:-NFTHND7Q-8, jvr:-M63HSDM7-1, jvr:-TJHVZCRZ-0, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-HQRFT0C6-B, jvr:-FWD2BGQ0-9, jvr:-W6SQV79N-S, jvr:-NKM836P1-M, jvr:-NB0XHT3S-N, jvr:-L6C0XPHT-4, jvr:-G4R176S9-J, jvr:-THHNVC7V-3, jvr:-Q3979798-W ; skos:altLabel "Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-"@fr, "Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-"@en, "MUN5LYG46H"@en, "MUN5LYG46H"@fr, "437-38-7 (Fentanyl)"@fr, "437-38-7 (Fentanyl)"@en, "990-73-8 (citrate)"@fr, "990-73-8 (citrate)"@en, "UF599785JZ"@fr, "UF599785JZ"@en, "Phentanyl"@en ; skos:hiddenLabel "Sublimaze"@en, "R4263"@fr, "Transmucosal Oral Fentanyl Citrate"@en, "Fentanyl Citrate"@en, "R-4263"@fr, "R-4263"@en, "Fentora"@en, "Fentanest"@en, "Duragesic"@en, "Citrate de fentanyl"@fr, "Durogesic"@en ; skos:prefLabel "Fentanyl"@en, "Fentanyl"@fr ; dc:established "1966-01-01"^^xsd:date ; mesh:pharmacologicalAction jvr:-XGBKP9G8-T, jvr:-XN0HMQQ9-C, jvr:-RMSM6LXT-R, jvr:-X8QHR726-Z ; dc:modified "2017-05-24"^^xsd:date ; skos:definition "A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)"@en ; skos:inScheme jvr: ; a mesh:Descriptor, skos:Concept ; dc:created "1999-01-01"^^xsd:date ; skos:broader jvr:-CQ2KMNMH-W ; skos:narrower jvr:-SL9SPLFM-9, jvr:-F32T283B-G ; owl:sameAs . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-X8QHR726-Z skos:prefLabel "Analgésiques morphiniques"@fr, "Analgesics, Opioid"@en ; a mesh:Descriptor, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-XN0HMQQ9-C skos:prefLabel "Stupéfiants"@fr, "Narcotics"@en ; a mesh:Descriptor, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .